Genetic Risk Factors for Portopulmonary Hypertension in Patients with Advanced Liver Disease
AUTOR(ES)
Roberts, Kari E.
FONTE
American Thoracic Society
RESUMO
Rationale: Portopulmonary hypertension (PPHTN) occurs in 6% of liver transplant candidates. The pathogenesis of this complication of portal hypertension is poorly understood.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2675568Documentos Relacionados
- Serotonin Transporter Polymorphisms in Patients With Portopulmonary Hypertension
- RISK FACTORS FOR HEPATOCELLULAR CARCINOMA IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
- Evaluation of nutritional indicators and body composition in patients with advanced liver disease enrolled for liver transplantation
- Risk factors associated with nonalcoholic fatty liver disease evaluated by elastography in patients with type 2 diabetes
- Risk factors for pulmonary hypertension in patients receiving maintenance peritoneal dialysis
